Company / EPS (Basic)
ACCENDRA HEALTH INC/VA/ EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.54
FY2025
5-year range
-$1.03 / $3.05
FY2021-FY2025
Trend
-280.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Basic) changed -280% YoY in FY2025, a notable deviation from the 5-year average annual change of +25%.
Based on SEC 10-K filings.
-0.54 in FY2025.
Declined from $3.05 to $-0.54 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) decreased 280.0% year-over-year.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.54 | -280.0% |
| FY2024 | $0.30 | -90.2% |
| FY2023 | $3.05 | +548.9% |
| FY2022 | $0.47 | +145.6% |
| FY2021 | -$1.03 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $1.06 | -39.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026